Watch Demo

Global STD Testing Industry

Global STD Testing Industry

  • Publish Date:October 2022

  • Number of Pages:197

  • Report ID:5960877

  • Format:PDF

  • Publisher:Global Industry Analysts

$ 5450

Summary

Abstract:

What’s New for 2022?

Global competitiveness and key competitor percentage market shares
Market presence across multiple geographies - Strong/Active/Niche/Trivial
Online interactive peer-to-peer collaborative bespoke updates
Access to our digital archives and MarketGlass Research Platform
Complimentary updates for one year

Global STD Testing Market to Reach $240.4 Billion by 2027

In the changed post COVID-19 business landscape, the global market for STD Testing estimated at US$147.1 Billion in the year 2020, is projected to reach a revised size of US$240.4 Billion by 2027, growing at a CAGR of 7.3% over the analysis period 2020-2027. Chlamydia Testing, one of the segments analyzed in the report, is projected to record a 8.1% CAGR and reach US$90.4 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Syphilis Testing segment is readjusted to a revised 8.4% CAGR for the next 7-year period.

The U.S. Market is Estimated at $39.8 Billion, While China is Forecast to Grow at 11.1% CAGR

The STD Testing market in the U.S. is estimated at US$39.8 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$53.7 Billion by the year 2027 trailing a CAGR of 11.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.9% and 6.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.7% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$32.9 Billion by the year 2027.

Gonorrhea Testing Segment to Record 7.2% CAGR

In the global Gonorrhea Testing segment, USA, Canada, Japan, China and Europe will drive the 7.2% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$28.7 Billion in the year 2020 will reach a projected size of US$45 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Latin America will expand at a 8.5% CAGR through the analysis period.

Select Competitors (Total 47 Featured) -
Alere, Inc.
Becton, Dickinson and Company
bioMerieux SA
Danaher Corporation
F. Hoffmann-La Roche AG
Hologic, Inc.

Table of contents

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
STD Testing - Global Key Competitors Percentage Market Share in
2022 (E)
Impact of Covid-19 and a Looming Global Recession
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for STD
Testing by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 2: World Historic Review for STD Testing by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 3: World 15-Year Perspective for STD Testing by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets for Years 2012, 2021 & 2027

Table 4: World Recent Past, Current & Future Analysis for
Chlamydia Testing by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2020 through 2027 and % CAGR

Table 5: World Historic Review for Chlamydia Testing by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 6: World 15-Year Perspective for Chlamydia Testing by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 7: World Recent Past, Current & Future Analysis for
Syphilis Testing by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2020 through 2027 and % CAGR

Table 8: World Historic Review for Syphilis Testing by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 9: World 15-Year Perspective for Syphilis Testing by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 10: World Recent Past, Current & Future Analysis for
Gonorrhea Testing by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2020 through 2027 and % CAGR

Table 11: World Historic Review for Gonorrhea Testing by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 12: World 15-Year Perspective for Gonorrhea Testing by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 13: World Recent Past, Current & Future Analysis for
Herpes Simplex Virus Testing by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2020 through 2027 and % CAGR

Table 14: World Historic Review for Herpes Simplex Virus
Testing by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 15: World 15-Year Perspective for Herpes Simplex Virus
Testing by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2021 &
2027

Table 16: World Recent Past, Current & Future Analysis for
Human Papilloma Virus Testing by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2020 through 2027 and % CAGR

Table 17: World Historic Review for Human Papilloma Virus
Testing by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 18: World 15-Year Perspective for Human Papilloma Virus
Testing by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2021 &
2027

Table 19: World Recent Past, Current & Future Analysis for
Human Immunodeficiency Virus Testing by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2020 through 2027 and % CAGR

Table 20: World Historic Review for Human Immunodeficiency
Virus Testing by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 21: World 15-Year Perspective for Human Immunodeficiency
Virus Testing by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2012, 2021 & 2027

Table 22: World Recent Past, Current & Future Analysis for
Chancroid Testing by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2020 through 2027 and % CAGR

Table 23: World Historic Review for Chancroid Testing by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 24: World 15-Year Perspective for Chancroid Testing by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 25: World Recent Past, Current & Future Analysis for
Laboratory Testing by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2020 through 2027 and % CAGR

Table 26: World Historic Review for Laboratory Testing by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 27: World 15-Year Perspective for Laboratory Testing by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 28: World Recent Past, Current & Future Analysis for
Point of Care (PoC) testing by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2020 through 2027 and % CAGR

Table 29: World Historic Review for Point of Care (PoC) testing
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 30: World 15-Year Perspective for Point of Care (PoC)
testing by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2021 &
2027

Table 31: World STD Testing Market Analysis of Annual Sales in
US$ Million for Years 2012 through 2027

III. MARKET ANALYSIS

UNITED STATES
STD Testing Market Presence - Strong/Active/Niche/Trivial - Key
Competitors in the United States for 2022 (E)
Table 32: USA Recent Past, Current & Future Analysis for STD
Testing by STD Type - Chlamydia Testing, Syphilis Testing,
Gonorrhea Testing, Herpes Simplex Virus Testing, Human
Papilloma Virus Testing, Human Immunodeficiency Virus Testing
and Chancroid Testing - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 33: USA Historic Review for STD Testing by STD Type -
Chlamydia Testing, Syphilis Testing, Gonorrhea Testing, Herpes
Simplex Virus Testing, Human Papilloma Virus Testing, Human
Immunodeficiency Virus Testing and Chancroid Testing Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 34: USA 15-Year Perspective for STD Testing by STD Type -
Percentage Breakdown of Value Sales for Chlamydia Testing,
Syphilis Testing, Gonorrhea Testing, Herpes Simplex Virus
Testing, Human Papilloma Virus Testing, Human Immunodeficiency
Virus Testing and Chancroid Testing for the Years 2012, 2021 &
2027

Table 35: USA Recent Past, Current & Future Analysis for STD
Testing by Location - Laboratory Testing and Point of Care
(PoC) testing - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 36: USA Historic Review for STD Testing by Location -
Laboratory Testing and Point of Care (PoC) testing Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 37: USA 15-Year Perspective for STD Testing by Location -
Percentage Breakdown of Value Sales for Laboratory Testing and
Point of Care (PoC) testing for the Years 2012, 2021 & 2027

CANADA
Table 38: Canada Recent Past, Current & Future Analysis for STD
Testing by STD Type - Chlamydia Testing, Syphilis Testing,
Gonorrhea Testing, Herpes Simplex Virus Testing, Human
Papilloma Virus Testing, Human Immunodeficiency Virus Testing
and Chancroid Testing - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 39: Canada Historic Review for STD Testing by STD Type -
Chlamydia Testing, Syphilis Testing, Gonorrhea Testing, Herpes
Simplex Virus Testing, Human Papilloma Virus Testing, Human
Immunodeficiency Virus Testing and Chancroid Testing Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 40: Canada 15-Year Perspective for STD Testing by STD
Type - Percentage Breakdown of Value Sales for Chlamydia
Testing, Syphilis Testing, Gonorrhea Testing, Herpes Simplex
Virus Testing, Human Papilloma Virus Testing, Human
Immunodeficiency Virus Testing and Chancroid Testing for the
Years 2012, 2021 & 2027

Table 41: Canada Recent Past, Current & Future Analysis for STD
Testing by Location - Laboratory Testing and Point of Care
(PoC) testing - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 42: Canada Historic Review for STD Testing by Location -
Laboratory Testing and Point of Care (PoC) testing Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 43: Canada 15-Year Perspective for STD Testing by
Location - Percentage Breakdown of Value Sales for Laboratory
Testing and Point of Care (PoC) testing for the Years 2012,
2021 & 2027

JAPAN
STD Testing Market Presence - Strong/Active/Niche/Trivial - Key
Competitors in Japan for 2022 (E)
Table 44: Japan Recent Past, Current & Future Analysis for STD
Testing by STD Type - Chlamydia Testing, Syphilis Testing,
Gonorrhea Testing, Herpes Simplex Virus Testing, Human
Papilloma Virus Testing, Human Immunodeficiency Virus Testing
and Chancroid Testing - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 45: Japan Historic Review for STD Testing by STD Type -
Chlamydia Testing, Syphilis Testing, Gonorrhea Testing, Herpes
Simplex Virus Testing, Human Papilloma Virus Testing, Human
Immunodeficiency Virus Testing and Chancroid Testing Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 46: Japan 15-Year Perspective for STD Testing by STD Type -
Percentage Breakdown of Value Sales for Chlamydia Testing,
Syphilis Testing, Gonorrhea Testing, Herpes Simplex Virus
Testing, Human Papilloma Virus Testing, Human Immunodeficiency
Virus Testing and Chancroid Testing for the Years 2012, 2021 &
2027

Table 47: Japan Recent Past, Current & Future Analysis for STD
Testing by Location - Laboratory Testing and Point of Care
(PoC) testing - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 48: Japan Historic Review for STD Testing by Location -
Laboratory Testing and Point of Care (PoC) testing Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 49: Japan 15-Year Perspective for STD Testing by Location -
Percentage Breakdown of Value Sales for Laboratory Testing
and Point of Care (PoC) testing for the Years 2012, 2021 & 2027

CHINA
STD Testing Market Presence - Strong/Active/Niche/Trivial - Key
Competitors in China for 2022 (E)
Table 50: China Recent Past, Current & Future Analysis for STD
Testing by STD Type - Chlamydia Testing, Syphilis Testing,
Gonorrhea Testing, Herpes Simplex Virus Testing, Human
Papilloma Virus Testing, Human Immunodeficiency Virus Testing
and Chancroid Testing - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 51: China Historic Review for STD Testing by STD Type -
Chlamydia Testing, Syphilis Testing, Gonorrhea Testing, Herpes
Simplex Virus Testing, Human Papilloma Virus Testing, Human
Immunodeficiency Virus Testing and Chancroid Testing Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 52: China 15-Year Perspective for STD Testing by STD Type -
Percentage Breakdown of Value Sales for Chlamydia Testing,
Syphilis Testing, Gonorrhea Testing, Herpes Simplex Virus
Testing, Human Papilloma Virus Testing, Human Immunodeficiency
Virus Testing and Chancroid Testing for the Years 2012, 2021 &
2027

Table 53: China Recent Past, Current & Future Analysis for STD
Testing by Location - Laboratory Testing and Point of Care
(PoC) testing - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 54: China Historic Review for STD Testing by Location -
Laboratory Testing and Point of Care (PoC) testing Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 55: China 15-Year Perspective for STD Testing by Location -
Percentage Breakdown of Value Sales for Laboratory Testing
and Point of Care (PoC) testing for the Years 2012, 2021 & 2027

EUROPE
STD Testing Market Presence - Strong/Active/Niche/Trivial - Key
Competitors in Europe for 2022 (E)
Table 56: Europe Recent Past, Current & Future Analysis for STD
Testing by Geographic Region - France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 57: Europe Historic Review for STD Testing by Geographic
Region - France, Germany, Italy, UK, Spain, Russia and Rest of
Europe Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 58: Europe 15-Year Perspective for STD Testing by
Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK, Spain, Russia and Rest of Europe
Markets for Years 2012, 2021 & 2027

Table 59: Europe Recent Past, Current & Future Analysis for STD
Testing by STD Type - Chlamydia Testing, Syphilis Testing,
Gonorrhea Testing, Herpes Simplex Virus Testing, Human
Papilloma Virus Testing, Human Immunodeficiency Virus Testing
and Chancroid Testing - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 60: Europe Historic Review for STD Testing by STD Type -
Chlamydia Testing, Syphilis Testing, Gonorrhea Testing, Herpes
Simplex Virus Testing, Human Papilloma Virus Testing, Human
Immunodeficiency Virus Testing and Chancroid Testing Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 61: Europe 15-Year Perspective for STD Testing by STD
Type - Percentage Breakdown of Value Sales for Chlamydia
Testing, Syphilis Testing, Gonorrhea Testing, Herpes Simplex
Virus Testing, Human Papilloma Virus Testing, Human
Immunodeficiency Virus Testing and Chancroid Testing for the
Years 2012, 2021 & 2027

Table 62: Europe Recent Past, Current & Future Analysis for STD
Testing by Location - Laboratory Testing and Point of Care
(PoC) testing - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 63: Europe Historic Review for STD Testing by Location -
Laboratory Testing and Point of Care (PoC) testing Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 64: Europe 15-Year Perspective for STD Testing by
Location - Percentage Breakdown of Value Sales for Laboratory
Testing and Point of Care (PoC) testing for the Years 2012,
2021 & 2027

FRANCE
STD Testing Market Presence - Strong/Active/Niche/Trivial - Key
Competitors in France for 2022 (E)
Table 65: France Recent Past, Current & Future Analysis for STD
Testing by STD Type - Chlamydia Testing, Syphilis Testing,
Gonorrhea Testing, Herpes Simplex Virus Testing, Human
Papilloma Virus Testing, Human Immunodeficiency Virus Testing
and Chancroid Testing - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 66: France Historic Review for STD Testing by STD Type -
Chlamydia Testing, Syphilis Testing, Gonorrhea Testing, Herpes
Simplex Virus Testing, Human Papilloma Virus Testing, Human
Immunodeficiency Virus Testing and Chancroid Testing Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 67: France 15-Year Perspective for STD Testing by STD
Type - Percentage Breakdown of Value Sales for Chlamydia
Testing, Syphilis Testing, Gonorrhea Testing, Herpes Simplex
Virus Testing, Human Papilloma Virus Testing, Human
Immunodeficiency Virus Testing and Chancroid Testing for the
Years 2012, 2021 & 2027

Table 68: France Recent Past, Current & Future Analysis for STD
Testing by Location - Laboratory Testing and Point of Care
(PoC) testing - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 69: France Historic Review for STD Testing by Location -
Laboratory Testing and Point of Care (PoC) testing Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 70: France 15-Year Perspective for STD Testing by
Location - Percentage Breakdown of Value Sales for Laboratory
Testing and Point of Care (PoC) testing for the Years 2012,
2021 & 2027

GERMANY
STD Testing Market Presence - Strong/Active/Niche/Trivial - Key
Competitors in Germany for 2022 (E)
Table 71: Germany Recent Past, Current & Future Analysis for
STD Testing by STD Type - Chlamydia Testing, Syphilis Testing,
Gonorrhea Testing, Herpes Simplex Virus Testing, Human
Papilloma Virus Testing, Human Immunodeficiency Virus Testing
and Chancroid Testing - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 72: Germany Historic Review for STD Testing by STD Type -
Chlamydia Testing, Syphilis Testing, Gonorrhea Testing, Herpes
Simplex Virus Testing, Human Papilloma Virus Testing, Human
Immunodeficiency Virus Testing and Chancroid Testing Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 73: Germany 15-Year Perspective for STD Testing by STD
Type - Percentage Breakdown of Value Sales for Chlamydia
Testing, Syphilis Testing, Gonorrhea Testing, Herpes Simplex
Virus Testing, Human Papilloma Virus Testing, Human
Immunodeficiency Virus Testing and Chancroid Testing for the
Years 2012, 2021 & 2027

Table 74: Germany Recent Past, Current & Future Analysis for
STD Testing by Location - Laboratory Testing and Point of Care
(PoC) testing - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 75: Germany Historic Review for STD Testing by Location -
Laboratory Testing and Point of Care (PoC) testing Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 76: Germany 15-Year Perspective for STD Testing by
Location - Percentage Breakdown of Value Sales for Laboratory
Testing and Point of Care (PoC) testing for the Years 2012,
2021 & 2027

ITALY
Table 77: Italy Recent Past, Current & Future Analysis for STD
Testing by STD Type - Chlamydia Testing, Syphilis Testing,
Gonorrhea Testing, Herpes Simplex Virus Testing, Human
Papilloma Virus Testing, Human Immunodeficiency Virus Testing
and Chancroid Testing - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 78: Italy Historic Review for STD Testing by STD Type -
Chlamydia Testing, Syphilis Testing, Gonorrhea Testing, Herpes
Simplex Virus Testing, Human Papilloma Virus Testing, Human
Immunodeficiency Virus Testing and Chancroid Testing Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 79: Italy 15-Year Perspective for STD Testing by STD Type -
Percentage Breakdown of Value Sales for Chlamydia Testing,
Syphilis Testing, Gonorrhea Testing, Herpes Simplex Virus
Testing, Human Papilloma Virus Testing, Human Immunodeficiency
Virus Testing and Chancroid Testing for the Years 2012, 2021 &
2027

Table 80: Italy Recent Past, Current & Future Analysis for STD
Testing by Location - Laboratory Testing and Point of Care
(PoC) testing - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 81: Italy Historic Review for STD Testing by Location -
Laboratory Testing and Point of Care (PoC) testing Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 82: Italy 15-Year Perspective for STD Testing by Location -
Percentage Breakdown of Value Sales for Laboratory Testing
and Point of Care (PoC) testing for the Years 2012, 2021 & 2027

UNITED KINGDOM
STD Testing Market Presence - Strong/Active/Niche/Trivial - Key
Competitors in the United Kingdom for 2022 (E)
Table 83: UK Recent Past, Current & Future Analysis for STD
Testing by STD Type - Chlamydia Testing, Syphilis Testing,
Gonorrhea Testing, Herpes Simplex Virus Testing, Human
Papilloma Virus Testing, Human Immunodeficiency Virus Testing
and Chancroid Testing - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 84: UK Historic Review for STD Testing by STD Type -
Chlamydia Testing, Syphilis Testing, Gonorrhea Testing, Herpes
Simplex Virus Testing, Human Papilloma Virus Testing, Human
Immunodeficiency Virus Testing and Chancroid Testing Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 85: UK 15-Year Perspective for STD Testing by STD Type -
Percentage Breakdown of Value Sales for Chlamydia Testing,
Syphilis Testing, Gonorrhea Testing, Herpes Simplex Virus
Testing, Human Papilloma Virus Testing, Human Immunodeficiency
Virus Testing and Chancroid Testing for the Years 2012, 2021 &
2027

Table 86: UK Recent Past, Current & Future Analysis for STD
Testing by Location - Laboratory Testing and Point of Care
(PoC) testing - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 87: UK Historic Review for STD Testing by Location -
Laboratory Testing and Point of Care (PoC) testing Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 88: UK 15-Year Perspective for STD Testing by Location -
Percentage Breakdown of Value Sales for Laboratory Testing and
Point of Care (PoC) testing for the Years 2012, 2021 & 2027

SPAIN
Table 89: Spain Recent Past, Current & Future Analysis for STD
Testing by STD Type - Chlamydia Testing, Syphilis Testing,
Gonorrhea Testing, Herpes Simplex Virus Testing, Human
Papilloma Virus Testing, Human Immunodeficiency Virus Testing
and Chancroid Testing - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 90: Spain Historic Review for STD Testing by STD Type -
Chlamydia Testing, Syphilis Testing, Gonorrhea Testing, Herpes
Simplex Virus Testing, Human Papilloma Virus Testing, Human
Immunodeficiency Virus Testing and Chancroid Testing Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 91: Spain 15-Year Perspective for STD Testing by STD Type -
Percentage Breakdown of Value Sales for Chlamydia Testing,
Syphilis Testing, Gonorrhea Testing, Herpes Simplex Virus
Testing, Human Papilloma Virus Testing, Human Immunodeficiency
Virus Testing and Chancroid Testing for the Years 2012, 2021 &
2027

Table 92: Spain Recent Past, Current & Future Analysis for STD
Testing by Location - Laboratory Testing and Point of Care
(PoC) testing - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 93: Spain Historic Review for STD Testing by Location -
Laboratory Testing and Point of Care (PoC) testing Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 94: Spain 15-Year Perspective for STD Testing by Location -
Percentage Breakdown of Value Sales for Laboratory Testing
and Point of Care (PoC) testing for the Years 2012, 2021 & 2027

RUSSIA
Table 95: Russia Recent Past, Current & Future Analysis for STD
Testing by STD Type - Chlamydia Testing, Syphilis Testing,
Gonorrhea Testing, Herpes Simplex Virus Testing, Human
Papilloma Virus Testing, Human Immunodeficiency Virus Testing
and Chancroid Testing - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 96: Russia Historic Review for STD Testing by STD Type -
Chlamydia Testing, Syphilis Testing, Gonorrhea Testing, Herpes
Simplex Virus Testing, Human Papilloma Virus Testing, Human
Immunodeficiency Virus Testing and Chancroid Testing Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 97: Russia 15-Year Perspective for STD Testing by STD
Type - Percentage Breakdown of Value Sales for Chlamydia
Testing, Syphilis Testing, Gonorrhea Testing, Herpes Simplex
Virus Testing, Human Papilloma Virus Testing, Human
Immunodeficiency Virus Testing and Chancroid Testing for the
Years 2012, 2021 & 2027

Table 98: Russia Recent Past, Current & Future Analysis for STD
Testing by Location - Laboratory Testing and Point of Care
(PoC) testing - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 99: Russia Historic Review for STD Testing by Location -
Laboratory Testing and Point of Care (PoC) testing Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 100: Russia 15-Year Perspective for STD Testing by
Location - Percentage Breakdown of Value Sales for Laboratory
Testing and Point of Care (PoC) testing for the Years 2012,
2021 & 2027

REST OF EUROPE
Table 101: Rest of Europe Recent Past, Current & Future
Analysis for STD Testing by STD Type - Chlamydia Testing,
Syphilis Testing, Gonorrhea Testing, Herpes Simplex Virus
Testing, Human Papilloma Virus Testing, Human Immunodeficiency
Virus Testing and Chancroid Testing - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 102: Rest of Europe Historic Review for STD Testing by
STD Type - Chlamydia Testing, Syphilis Testing, Gonorrhea
Testing, Herpes Simplex Virus Testing, Human Papilloma Virus
Testing, Human Immunodeficiency Virus Testing and Chancroid
Testing Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 103: Rest of Europe 15-Year Perspective for STD Testing
by STD Type - Percentage Breakdown of Value Sales for Chlamydia
Testing, Syphilis Testing, Gonorrhea Testing, Herpes Simplex
Virus Testing, Human Papilloma Virus Testing, Human
Immunodeficiency Virus Testing and Chancroid Testing for the
Years 2012, 2021 & 2027

Table 104: Rest of Europe Recent Past, Current & Future
Analysis for STD Testing by Location - Laboratory Testing and
Point of Care (PoC) testing - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027 and % CAGR

Table 105: Rest of Europe Historic Review for STD Testing by
Location - Laboratory Testing and Point of Care (PoC) testing
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 106: Rest of Europe 15-Year Perspective for STD Testing
by Location - Percentage Breakdown of Value Sales for
Laboratory Testing and Point of Care (PoC) testing for the
Years 2012, 2021 & 2027

ASIA-PACIFIC
STD Testing Market Presence - Strong/Active/Niche/Trivial - Key
Competitors in Asia-Pacific for 2022 (E)
Table 107: Asia-Pacific Recent Past, Current & Future Analysis
for STD Testing by Geographic Region - Australia, India, South
Korea and Rest of Asia-Pacific Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 108: Asia-Pacific Historic Review for STD Testing by
Geographic Region - Australia, India, South Korea and Rest of
Asia-Pacific Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR

Table 109: Asia-Pacific 15-Year Perspective for STD Testing by
Geographic Region - Percentage Breakdown of Value Sales for
Australia, India, South Korea and Rest of Asia-Pacific Markets
for Years 2012, 2021 & 2027

Table 110: Asia-Pacific Recent Past, Current & Future Analysis
for STD Testing by STD Type - Chlamydia Testing, Syphilis
Testing, Gonorrhea Testing, Herpes Simplex Virus Testing, Human
Papilloma Virus Testing, Human Immunodeficiency Virus Testing
and Chancroid Testing - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 111: Asia-Pacific Historic Review for STD Testing by STD
Type - Chlamydia Testing, Syphilis Testing, Gonorrhea Testing,
Herpes Simplex Virus Testing, Human Papilloma Virus Testing,
Human Immunodeficiency Virus Testing and Chancroid Testing
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 112: Asia-Pacific 15-Year Perspective for STD Testing by

Please contact our Customer Support Center to get the complete Table of Contents

Methodology

Our market research methodology is designed to provide the clients with comprehensive and accurate information on various industries and markets. It includes data collection, primary interviews, macro-economic factor analysis, country-level data analysis etc.

The data is gathered from a wide range of sources, including industry reports, government statistics, and company financials. This data is then analyzed and cross-referenced to ensure its accuracy and reliability. Next, primary interviews are conducted with industry experts and key stakeholders to gather their insights and perspectives on the market. This information is then combined with the data collected to provide a complete picture of the market. Macro-economic factor analysis is also carried out to understand the impact of external factors on the market. Finally, country-level data analysis is performed to understand the market dynamics in specific regions and countries.

Reportlinker's market research methodology is designed to provide clients with a clear understanding of the market, its trends, and its future potential.